Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,595 public trials 1,040 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Completed

Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy

NCT00892736

Conditions
Adnexal Diseases, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +48 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View Trial Details
Completed

Ohio Colorectal Cancer Prevention Initiative

NCT01850654

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +29 more
Locations
  • Akron General Medical Center Akron, Ohio, United States
  • Akron City/St. Thomas Hospital (Summa Health System) Akron, Ohio, United States
  • Summa Barberton (Summa Health System) Barberton, Ohio, United States
  • Mercy Clermont Batavia, Ohio, United States
View all 49 locations
View Trial Details
Completed

Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

NCT02948075

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Federal State budget Scientific Agency "Russian Oncological Research Center n.a. N.N. Blokhin" Moscow, Russia
  • Medical Radiological Scientific Center n.a. A.F. Tsyb - branch of Federal State Budget Agency "Public Medical Scientific Radiology Center" of Ministry of Health of Russian Federation Obninsk, Russia
  • State Budget Agency of Stavropol Territory Healthcare Pyatigorsk Oncologic Dispensary Pyatigorsk, Russia
  • State Budget Agency of Healthcare "Leningradsky Regional Oncologic Dispensary" Saint Petersburg, Russia
View Trial Details
Completed

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

NCT00546078

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Augusta, Georgia, United States
  • GSK Investigational Site Bardstown, Kentucky, United States
  • GSK Investigational Site Louisville, Kentucky, United States
View all 17 locations
View Trial Details
Completed

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age

NCT00552279

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Brescia, Lombardy, Italy
  • GSK Investigational Site Lodi, Lombardy, Italy
  • GSK Investigational Site Milan, Lombardy, Italy
  • GSK Investigational Site Cagliari, Sardinia, Italy
View all 16 locations
View Trial Details
Completed

A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

NCT02146313

Conditions
Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, +16 more
Locations
  • Florida Cancer Specialists - Sarasota (North Catttlemen Rd) Sarasota, Florida, United States
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • Dana Farber Cancer Inst. Boston, Massachusetts, United States
  • Hackensack Univ Med Ctr Hackensack, New Jersey, United States
View Trial Details

Related conditions